Evidence map›Paper›PMID 25668673›Full record

ReviewHuman vaccines & immunotherapeutics2014

The host immune dynamics of pneumococcal colonization: implications for novel vaccine development.

M Nadeem Khan, Michael E Pichichero

Abstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Identification ofJournal of proteome research · 2025
    Article
  6. Article
  7. SARS-CoV-2 Spike Protein and Mouse Coronavirus Inhibit Biofilm Formation byInternational journal of molecular sciences · 2022
    Article
  8. Altered Signal Transduction in the Immune Response to Influenza Virus andInternational journal of molecular sciences · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Frontiers in immunology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M Nadeem Khana Center for Infectious Diseases and Immunology; Rochester General Hospital Research Institute ; Rochester , NY USA.
Michael E Pichichero

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human nasopharynx (NP) microbiota is complex and diverse and Streptococcus pneumoniae (pneumococcus) is a frequent member. In the first few years of life, children experience maturation of their immune system thereby conferring homeostatic balance in which pneumococci are typically rendered as harmless colonizers in the upper respiratory environment. Pneumococcal carriage declines in many children before they acquire capsular-specific antibodies, suggesting a capsule antibody-independent mechanism of natural protection against pneumococcal carriage in early childhood. A child's immune system in the first few years of life is Th2-skewed so as to avoid inflammation-induced immunopathology. Understanding Th1/Th2 and Th17 ontogeny in early life and how adjuvant vaccine formulations shift the balance of T helper-cell differentiation, may facilitate the development of new protein-based pneumococcal vaccines. This article will discuss the immune dynamics of pneumococcal colonization in infants. The discussion aims to benefit the design and improvement of protein subunit-based next-generation pneumococcal vaccines.

Indexed as

AnimalsCD4-Positive T-LymphocytesHumansInfantMiceNasopharynxPneumococcal VaccinesSerogroupStreptococcus pneumoniaeTh17 CellsVaccines, ConjugatePneumococcal VaccinesVaccines, ConjugatecolonizationimmunityIPDs, invasive pneumococcal diseasesMHC, major histocompatibility complexNP, nasopharynxOPAs, opsonophagocytic antibodiesPcpA, pneumococcal choline-binding protein APPS, pneumococcal polysaccharidesPPVs, pneumococcal polysaccharide vaccinesStreptococcus pneumoniaeT cellsvaccinesWCV, whole cell vaccine

Identifiers

PMID25668673
PMCPMC4514076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.